| 1 |
35063850 | Epigallocatechin 3-gallate: From green tea to cancer therapeutics. | 2022 Jun 15 |
1 |
| 2 |
33747527 | Tea polyphenol EGCG inhibited colorectal-cancer-cell proliferation and migration via downregulation of STAT3. | 2021 Jan |
7 |
| 3 |
33801973 | EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype. | 2021 Mar 10 |
1 |
| 4 |
31554961 | ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication. | 2020 Feb |
1 |
| 5 |
32326395 | Involvement of MicroRNA-296 in the Inhibitory Effect of Epigallocatechin Gallate against the Migratory Properties of Anoikis-Resistant Nasopharyngeal Carcinoma Cells. | 2020 Apr 15 |
2 |
| 6 |
30251267 | (-)-Epigallocatechin-3-gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr/Abl-mediated p38-MAPK/JNK and JAK2/STAT3/AKT signalling pathways. | 2019 Feb |
1 |
| 7 |
31114166 | Epigallocatechin-3-gallate enhances the osteoblastogenic differentiation of human adipose-derived stem cells. | 2019 |
1 |
| 8 |
27200496 | Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling. | 2017 Mar |
3 |
| 9 |
28703809 | Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. | 2017 Jul 13 |
1 |
| 10 |
25550533 | Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. | 2015 Jan |
3 |
| 11 |
25825203 | A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia. | 2015 Jul |
4 |
| 12 |
26345342 | Epigallocatechin-3-gallate (EGCG) Suppresses the Trafficking of Lymphocytes to Epidermal Melanocytes via Inhibition of JAK2: Its Implication for Vitiligo Treatment. | 2015 |
1 |
| 13 |
24038588 | Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway. | 2014 Jun |
1 |
| 14 |
24634598 | Reversal of Cisplatin resistance by epigallocatechin gallate is mediated by downregulation of axl and tyro 3 expression in human lung cancer cells. | 2014 Feb |
4 |
| 15 |
24065300 | Mechanism of the inhibition of the STAT3 signaling pathway by EGCG. | 2013 Dec |
16 |
| 16 |
22020144 | Green tea EGCG, T cells, and T cell-mediated autoimmune diseases. | 2012 Feb |
1 |
| 17 |
22313388 | (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells. | 2012 Mar 14 |
9 |
| 18 |
21633597 | (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. | 2011 May 14 |
10 |
| 19 |
21866460 | [(-)-Epigallocatechin-3-gallate reduces vascular endothelial growth factor expression in gastric cancer cells via suppressing activity]. | 2011 Aug |
2 |
| 20 |
19616927 | Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts. | 2010 Jul |
1 |
| 21 |
19221405 | (-)-Epigallocatechin-3-Gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation. | 2009 |
5 |
| 22 |
18463684 | Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. | 2008 Oct |
3 |
| 23 |
17341611 | Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. | 2006 Dec |
1 |
| 24 |
12440226 | Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. | 2002 Nov-Dec |
2 |
| 25 |
11751523 | Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. | 2001 Dec |
2 |